中华普通外科杂志
中華普通外科雜誌
중화보통외과잡지
CHINESE JOURNAL OF GENERAL SURGERY
2001年
1期
44-45
,共2页
齐德林%李国新%盛权根%黄祥成%余术祥%唐志宏
齊德林%李國新%盛權根%黃祥成%餘術祥%唐誌宏
제덕림%리국신%성권근%황상성%여술상%당지굉
乳腺肿瘤%腈类%放射性核素显像
乳腺腫瘤%腈類%放射性覈素顯像
유선종류%정류%방사성핵소현상
目的 评价99mTc-甲氧基异丁基异腈(MIBI)显 像鉴别乳房肿块良恶性的价值。 方法 对1 06例乳房肿块行99mTc-MIBI显像检查,全部病例均经手术治疗,与病理结果比 较。 结果 106例中乳腺癌56例,显像阳性4 8例,假阴性主要为肿块较小的乳腺癌;良性病变50例,显像阴性40例,假阳性主要为血供 丰富的大纤维腺瘤。该法诊断乳腺癌的灵敏度为85.7%、特异性为80.0%、阳性预告值82 .8%、阴性预告值83.3%、总正确诊断率为83.0%。 结论 99mTc-MIBI显像是鉴别乳房良恶性肿块的有效的、无创性检 查方法,但对大纤维腺瘤和较小的恶性肿块诊断作用较差。
目的 評價99mTc-甲氧基異丁基異腈(MIBI)顯 像鑒彆乳房腫塊良噁性的價值。 方法 對1 06例乳房腫塊行99mTc-MIBI顯像檢查,全部病例均經手術治療,與病理結果比 較。 結果 106例中乳腺癌56例,顯像暘性4 8例,假陰性主要為腫塊較小的乳腺癌;良性病變50例,顯像陰性40例,假暘性主要為血供 豐富的大纖維腺瘤。該法診斷乳腺癌的靈敏度為85.7%、特異性為80.0%、暘性預告值82 .8%、陰性預告值83.3%、總正確診斷率為83.0%。 結論 99mTc-MIBI顯像是鑒彆乳房良噁性腫塊的有效的、無創性檢 查方法,但對大纖維腺瘤和較小的噁性腫塊診斷作用較差。
목적 평개99mTc-갑양기이정기이정(MIBI)현 상감별유방종괴량악성적개치。 방법 대1 06례유방종괴행99mTc-MIBI현상검사,전부병례균경수술치료,여병리결과비 교。 결과 106례중유선암56례,현상양성4 8례,가음성주요위종괴교소적유선암;량성병변50례,현상음성40례,가양성주요위혈공 봉부적대섬유선류。해법진단유선암적령민도위85.7%、특이성위80.0%、양성예고치82 .8%、음성예고치83.3%、총정학진단솔위83.0%。 결론 99mTc-MIBI현상시감별유방량악성종괴적유효적、무창성검 사방법,단대대섬유선류화교소적악성종괴진단작용교차。
Objective To evaluate 99mTc-MI BI SPECT in differentiating malignancies from benign breast masses. Methods 106 patients with palpable breast mas ses underwent the examination of 99mTc-MIBI SPECT. Tentative di agnosis was evaluated by postoperative pathology in all cases. Results 48 of the 56 cases of breast carcinoma were preoperatively diagnosed by 99mTc-MIBI SPECT, 40 of the 50 pati ents with benign lesions were scintimammographically negative. The sensitivity of the examination was 85.7%, specificity was 80.0%, positive predictive value was 82.8%, negative predictive value was 83.3%, and the diagnostic accuracy w as 83.0%. False-positive results were found mainly in large fibroadenomas with abundant vascularities and false-negative results were mainly from some small malignant tumors. Conclusions 9 9mTc-MIBI SPECT is an effective, noninvasive diagnostic method for primar y breast cancer. But its value is limited in detecting large fibroadenoma and sm all malignancy.